Autori: Campione E., Zarabian N., Cosio T., Borselli C., Artosi F., Cont R., Sorge R., Shumak R.G., Costanza G., Rivieccio A., Gaziano R., Bianchi L.
Apremilast as a Potential Targeted Therapy for Metabolic Syndrome in Patients with Psoriasis: An Observational Analysis. Pharmaceuticals, 17(8), 989 (2024). DOI: 10.3390/ph17080989